nodes	percent_of_prediction	percent_of_DWPC	metapath
Amitriptyline—ABCB1—adrenal gland cancer	0.563	1	CbGaD
Amitriptyline—SLC6A2—sympathetic nervous system—adrenal gland cancer	0.00992	0.0813	CbGeAlD
Amitriptyline—HTR7—sympathetic nervous system—adrenal gland cancer	0.00956	0.0784	CbGeAlD
Amitriptyline—HTR7—vein—adrenal gland cancer	0.00895	0.0734	CbGeAlD
Amitriptyline—HTR2A—sympathetic nervous system—adrenal gland cancer	0.00596	0.0489	CbGeAlD
Amitriptyline—HTR2A—vein—adrenal gland cancer	0.00558	0.0457	CbGeAlD
Amitriptyline—CYP2C19—urine—adrenal gland cancer	0.00511	0.0419	CbGeAlD
Amitriptyline—NTRK2—gonad—adrenal gland cancer	0.00504	0.0413	CbGeAlD
Amitriptyline—NTRK2—adrenal gland—adrenal gland cancer	0.00439	0.036	CbGeAlD
Amitriptyline—CYP1A2—urine—adrenal gland cancer	0.00418	0.0343	CbGeAlD
Amitriptyline—CYP2C9—urine—adrenal gland cancer	0.00397	0.0325	CbGeAlD
Amitriptyline—CYP2E1—urine—adrenal gland cancer	0.00376	0.0308	CbGeAlD
Amitriptyline—KCNQ2—gonad—adrenal gland cancer	0.00351	0.0288	CbGeAlD
Amitriptyline—KCNQ2—pituitary gland—adrenal gland cancer	0.00343	0.0281	CbGeAlD
Amitriptyline—HTR2A—urine—adrenal gland cancer	0.00327	0.0268	CbGeAlD
Amitriptyline—KCND2—pituitary gland—adrenal gland cancer	0.00325	0.0266	CbGeAlD
Amitriptyline—CYP3A4—urine—adrenal gland cancer	0.00302	0.0248	CbGeAlD
Amitriptyline—CYP2D6—urine—adrenal gland cancer	0.00298	0.0244	CbGeAlD
Amitriptyline—KCND3—cardiac atrium—adrenal gland cancer	0.0029	0.0237	CbGeAlD
Amitriptyline—KCND3—adrenal gland—adrenal gland cancer	0.00253	0.0207	CbGeAlD
Amitriptyline—HRH2—cardiac atrium—adrenal gland cancer	0.00226	0.0185	CbGeAlD
Amitriptyline—HRH2—adrenal gland—adrenal gland cancer	0.00197	0.0162	CbGeAlD
Amitriptyline—SIGMAR1—adrenal cortex—adrenal gland cancer	0.00162	0.0133	CbGeAlD
Amitriptyline—SIGMAR1—cardiac atrium—adrenal gland cancer	0.00134	0.011	CbGeAlD
Amitriptyline—SIGMAR1—pituitary gland—adrenal gland cancer	0.00131	0.0108	CbGeAlD
Amitriptyline—ALB—adrenal gland—adrenal gland cancer	0.00121	0.00996	CbGeAlD
Amitriptyline—SLC6A2—gonad—adrenal gland cancer	0.00119	0.00978	CbGeAlD
Amitriptyline—SIGMAR1—adrenal gland—adrenal gland cancer	0.00117	0.00961	CbGeAlD
Amitriptyline—HTR7—gonad—adrenal gland cancer	0.00115	0.00942	CbGeAlD
Amitriptyline—CYP2B6—adrenal cortex—adrenal gland cancer	0.00106	0.0087	CbGeAlD
Amitriptyline—DRD2—pituitary gland—adrenal gland cancer	0.00106	0.00869	CbGeAlD
Amitriptyline—HTR1A—adrenal gland—adrenal gland cancer	0.00105	0.00859	CbGeAlD
Amitriptyline—SLC6A2—adrenal gland—adrenal gland cancer	0.00104	0.00852	CbGeAlD
Amitriptyline—HTR7—adrenal gland—adrenal gland cancer	0.001	0.00821	CbGeAlD
Amitriptyline—ADRA1A—adrenal gland—adrenal gland cancer	0.000966	0.00792	CbGeAlD
Amitriptyline—CYP2C8—pituitary gland—adrenal gland cancer	0.000956	0.00784	CbGeAlD
Amitriptyline—CYP2B6—gonad—adrenal gland cancer	0.000879	0.0072	CbGeAlD
Amitriptyline—ADRA2A—gonad—adrenal gland cancer	0.000843	0.00691	CbGeAlD
Amitriptyline—ADRA2A—cardiac atrium—adrenal gland cancer	0.000842	0.0069	CbGeAlD
Amitriptyline—ADRA2A—pituitary gland—adrenal gland cancer	0.000822	0.00674	CbGeAlD
Amitriptyline—CYP2B6—adrenal gland—adrenal gland cancer	0.000766	0.00628	CbGeAlD
Amitriptyline—HRH1—adrenal gland—adrenal gland cancer	0.000748	0.00613	CbGeAlD
Amitriptyline—ADRA2A—adrenal gland—adrenal gland cancer	0.000735	0.00602	CbGeAlD
Amitriptyline—CYP2E1—adrenal gland—adrenal gland cancer	0.000719	0.00589	CbGeAlD
Amitriptyline—HTR2A—gonad—adrenal gland cancer	0.000717	0.00588	CbGeAlD
Amitriptyline—HTR2A—pituitary gland—adrenal gland cancer	0.000699	0.00573	CbGeAlD
Amitriptyline—HTR2A—adrenal gland—adrenal gland cancer	0.000625	0.00512	CbGeAlD
Amitriptyline—ABCB1—adrenal cortex—adrenal gland cancer	0.000567	0.00465	CbGeAlD
Amitriptyline—Epinastine—ABCB1—adrenal gland cancer	0.000542	0.235	CrCbGaD
Amitriptyline—ABCB1—gonad—adrenal gland cancer	0.00047	0.00385	CbGeAlD
Amitriptyline—ABCB1—pituitary gland—adrenal gland cancer	0.000458	0.00376	CbGeAlD
Amitriptyline—ABCB1—adrenal gland—adrenal gland cancer	0.000409	0.00336	CbGeAlD
Amitriptyline—Clomipramine—ABCB1—adrenal gland cancer	0.000287	0.124	CrCbGaD
Amitriptyline—Chlorprothixene—ABCB1—adrenal gland cancer	0.000285	0.124	CrCbGaD
Amitriptyline—Trimipramine—ABCB1—adrenal gland cancer	0.000264	0.114	CrCbGaD
Amitriptyline—Promethazine—ABCB1—adrenal gland cancer	0.000254	0.11	CrCbGaD
Amitriptyline—Doxepin—ABCB1—adrenal gland cancer	0.000251	0.109	CrCbGaD
Amitriptyline—Desipramine—ABCB1—adrenal gland cancer	0.000231	0.0999	CrCbGaD
Amitriptyline—Imipramine—ABCB1—adrenal gland cancer	0.000196	0.0847	CrCbGaD
Amitriptyline—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.61e-05	8.34e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CDC42—adrenal gland cancer	2.61e-05	8.34e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—BRAF—adrenal gland cancer	2.6e-05	8.33e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—BRAF—adrenal gland cancer	2.6e-05	8.32e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CDC42—adrenal gland cancer	2.6e-05	8.31e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—POMC—adrenal gland cancer	2.6e-05	8.31e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.59e-05	8.3e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—BRAF—adrenal gland cancer	2.58e-05	8.27e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—BAD—adrenal gland cancer	2.58e-05	8.27e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CDC42—adrenal gland cancer	2.57e-05	8.23e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—IGF2—adrenal gland cancer	2.57e-05	8.21e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CDC42—adrenal gland cancer	2.57e-05	8.21e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—POMC—adrenal gland cancer	2.56e-05	8.2e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling by GPCR—EGFR—adrenal gland cancer	2.56e-05	8.19e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—GNAS—adrenal gland cancer	2.55e-05	8.17e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—GNAS—adrenal gland cancer	2.54e-05	8.14e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—MED12—adrenal gland cancer	2.54e-05	8.14e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—BRAF—adrenal gland cancer	2.53e-05	8.09e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—IGF2—adrenal gland cancer	2.53e-05	8.08e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling by GPCR—EGFR—adrenal gland cancer	2.52e-05	8.07e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling by GPCR—EGFR—adrenal gland cancer	2.52e-05	8.07e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—IGF2—adrenal gland cancer	2.52e-05	8.06e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—IGF2—adrenal gland cancer	2.51e-05	8.04e-05	CbGpPWpGaD
Amitriptyline—HRH4—Signaling Pathways—EGFR—adrenal gland cancer	2.51e-05	8.02e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—ABCB1—adrenal gland cancer	2.51e-05	8.02e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—IGF2—adrenal gland cancer	2.5e-05	8.01e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling by GPCR—EGFR—adrenal gland cancer	2.5e-05	8.01e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—GNAS—adrenal gland cancer	2.5e-05	8.01e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—GNAS—adrenal gland cancer	2.5e-05	8.01e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—GNAS—adrenal gland cancer	2.5e-05	7.99e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—GNAS—adrenal gland cancer	2.5e-05	7.99e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—GNAS—adrenal gland cancer	2.49e-05	7.97e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—POMC—adrenal gland cancer	2.49e-05	7.96e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—GNAS—adrenal gland cancer	2.48e-05	7.94e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—IGF1R—adrenal gland cancer	2.48e-05	7.94e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—IGF2—adrenal gland cancer	2.48e-05	7.94e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—IGF2—adrenal gland cancer	2.47e-05	7.91e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—GNAS—adrenal gland cancer	2.46e-05	7.87e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—BRAF—adrenal gland cancer	2.46e-05	7.86e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—ABCB1—adrenal gland cancer	2.45e-05	7.86e-05	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—CTNNB1—adrenal gland cancer	2.45e-05	7.85e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—BAD—adrenal gland cancer	2.45e-05	7.85e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling by GPCR—EGFR—adrenal gland cancer	2.45e-05	7.85e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—GNAS—adrenal gland cancer	2.45e-05	7.85e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	2.45e-05	7.84e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—IGF1R—adrenal gland cancer	2.44e-05	7.81e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—IGF1R—adrenal gland cancer	2.44e-05	7.8e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—TERT—adrenal gland cancer	2.43e-05	7.79e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—IGF1R—adrenal gland cancer	2.43e-05	7.77e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—BAD—adrenal gland cancer	2.43e-05	7.77e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—BAD—adrenal gland cancer	2.43e-05	7.77e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—IGF1R—adrenal gland cancer	2.42e-05	7.75e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—TERT—adrenal gland cancer	2.42e-05	7.75e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—IGF1R—adrenal gland cancer	2.4e-05	7.67e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—IGF1R—adrenal gland cancer	2.39e-05	7.65e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CDC42—adrenal gland cancer	2.38e-05	7.63e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—POMC—adrenal gland cancer	2.38e-05	7.62e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	2.38e-05	7.62e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling by GPCR—EGFR—adrenal gland cancer	2.38e-05	7.62e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—BRAF—adrenal gland cancer	2.35e-05	7.53e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.33e-05	7.45e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PRKACA—adrenal gland cancer	2.32e-05	7.44e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—TERT—adrenal gland cancer	2.32e-05	7.42e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IGF2—adrenal gland cancer	2.3e-05	7.35e-05	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—EGFR—adrenal gland cancer	2.28e-05	7.31e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling by GPCR—EGFR—adrenal gland cancer	2.28e-05	7.29e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—GNAS—adrenal gland cancer	2.28e-05	7.29e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	2.27e-05	7.28e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—POMC—adrenal gland cancer	2.26e-05	7.23e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—POMC—adrenal gland cancer	2.24e-05	7.17e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—POMC—adrenal gland cancer	2.24e-05	7.17e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—BRAF—adrenal gland cancer	2.23e-05	7.14e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IGF1R—adrenal gland cancer	2.22e-05	7.11e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—BRAF—adrenal gland cancer	2.21e-05	7.08e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—BRAF—adrenal gland cancer	2.21e-05	7.08e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	2.19e-05	7.01e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—CTNNB1—adrenal gland cancer	2.18e-05	6.97e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	2.17e-05	6.95e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling by GPCR—EGFR—adrenal gland cancer	2.16e-05	6.92e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—GNAS—adrenal gland cancer	2.16e-05	6.92e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—GNAS—adrenal gland cancer	2.15e-05	6.88e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Hemostasis—TP53—adrenal gland cancer	2.15e-05	6.87e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling by GPCR—EGFR—adrenal gland cancer	2.14e-05	6.86e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling by GPCR—EGFR—adrenal gland cancer	2.14e-05	6.86e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—TERT—adrenal gland cancer	2.14e-05	6.84e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.12e-05	6.79e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—ABCB1—adrenal gland cancer	2.12e-05	6.79e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—BAD—adrenal gland cancer	2.12e-05	6.77e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—ABCB1—adrenal gland cancer	2.11e-05	6.75e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—BAD—adrenal gland cancer	2.11e-05	6.74e-05	CbGpPWpGaD
Amitriptyline—HRH4—Signaling Pathways—TP53—adrenal gland cancer	2.1e-05	6.73e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—TERT—adrenal gland cancer	2.1e-05	6.73e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—TERT—adrenal gland cancer	2.1e-05	6.71e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—TERT—adrenal gland cancer	2.09e-05	6.69e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—TERT—adrenal gland cancer	2.08e-05	6.67e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—TERT—adrenal gland cancer	2.06e-05	6.6e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—TERT—adrenal gland cancer	2.06e-05	6.59e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—BAD—adrenal gland cancer	2.02e-05	6.45e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—POMC—adrenal gland cancer	2e-05	6.4e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—MED12—adrenal gland cancer	1.96e-05	6.28e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—POMC—adrenal gland cancer	1.95e-05	6.24e-05	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—EGFR—adrenal gland cancer	1.94e-05	6.22e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—POMC—adrenal gland cancer	1.94e-05	6.21e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—GNAS—adrenal gland cancer	1.93e-05	6.18e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—BRAF—adrenal gland cancer	1.93e-05	6.17e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—BRAF—adrenal gland cancer	1.92e-05	6.13e-05	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—TP53—adrenal gland cancer	1.92e-05	6.13e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—TERT—adrenal gland cancer	1.91e-05	6.12e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—CTNNB1—adrenal gland cancer	1.91e-05	6.11e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	1.89e-05	6.06e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—GNAS—adrenal gland cancer	1.88e-05	6.03e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—CTNNB1—adrenal gland cancer	1.88e-05	6.02e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—CTNNB1—adrenal gland cancer	1.88e-05	6.01e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling by GPCR—EGFR—adrenal gland cancer	1.87e-05	5.98e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—CTNNB1—adrenal gland cancer	1.87e-05	5.97e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—BAD—adrenal gland cancer	1.86e-05	5.95e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—POMC—adrenal gland cancer	1.86e-05	5.95e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling by GPCR—EGFR—adrenal gland cancer	1.86e-05	5.95e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PRKACA—adrenal gland cancer	1.86e-05	5.94e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—BRAF—adrenal gland cancer	1.83e-05	5.87e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—POMC—adrenal gland cancer	1.83e-05	5.87e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—BAD—adrenal gland cancer	1.83e-05	5.85e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—CTNNB1—adrenal gland cancer	1.83e-05	5.85e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—BAD—adrenal gland cancer	1.82e-05	5.84e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—BAD—adrenal gland cancer	1.82e-05	5.82e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.81e-05	5.8e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—BAD—adrenal gland cancer	1.81e-05	5.8e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—BAD—adrenal gland cancer	1.8e-05	5.75e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—BAD—adrenal gland cancer	1.79e-05	5.73e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling by GPCR—EGFR—adrenal gland cancer	1.78e-05	5.69e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—GNAS—adrenal gland cancer	1.78e-05	5.68e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—CTNNB1—adrenal gland cancer	1.77e-05	5.68e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—GNAS—adrenal gland cancer	1.76e-05	5.63e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	1.74e-05	5.57e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	1.73e-05	5.53e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—EGFR—adrenal gland cancer	1.72e-05	5.52e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—POMC—adrenal gland cancer	1.72e-05	5.5e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—POMC—adrenal gland cancer	1.71e-05	5.48e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—CTNNB1—adrenal gland cancer	1.7e-05	5.44e-05	CbGpPWpGaD
Amitriptyline—ALB—Hemostasis—TP53—adrenal gland cancer	1.69e-05	5.42e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—BRAF—adrenal gland cancer	1.69e-05	5.41e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—POMC—adrenal gland cancer	1.69e-05	5.39e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—POMC—adrenal gland cancer	1.68e-05	5.39e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—POMC—adrenal gland cancer	1.68e-05	5.38e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—POMC—adrenal gland cancer	1.68e-05	5.38e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—POMC—adrenal gland cancer	1.68e-05	5.37e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—POMC—adrenal gland cancer	1.67e-05	5.35e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—BRAF—adrenal gland cancer	1.66e-05	5.33e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—BAD—adrenal gland cancer	1.66e-05	5.32e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—BRAF—adrenal gland cancer	1.66e-05	5.32e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—BRAF—adrenal gland cancer	1.66e-05	5.3e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—POMC—adrenal gland cancer	1.66e-05	5.3e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—POMC—adrenal gland cancer	1.65e-05	5.28e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—BRAF—adrenal gland cancer	1.65e-05	5.28e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—EGFR—adrenal gland cancer	1.64e-05	5.25e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—BRAF—adrenal gland cancer	1.63e-05	5.23e-05	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—TP53—adrenal gland cancer	1.63e-05	5.22e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—BRAF—adrenal gland cancer	1.63e-05	5.22e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—EGFR—adrenal gland cancer	1.61e-05	5.16e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	1.61e-05	5.16e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—EGFR—adrenal gland cancer	1.61e-05	5.15e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—EGFR—adrenal gland cancer	1.6e-05	5.14e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—EGFR—adrenal gland cancer	1.6e-05	5.12e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—CTNNB1—adrenal gland cancer	1.6e-05	5.11e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—CTNNB1—adrenal gland cancer	1.6e-05	5.11e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—PTGS2—adrenal gland cancer	1.59e-05	5.1e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—EGFR—adrenal gland cancer	1.58e-05	5.07e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—EGFR—adrenal gland cancer	1.58e-05	5.06e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—POMC—adrenal gland cancer	1.53e-05	4.91e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—BRAF—adrenal gland cancer	1.51e-05	4.85e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—EGFR—adrenal gland cancer	1.51e-05	4.84e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—GNAS—adrenal gland cancer	1.5e-05	4.81e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—EGFR—adrenal gland cancer	1.49e-05	4.77e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—EGFR—adrenal gland cancer	1.49e-05	4.76e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—EGFR—adrenal gland cancer	1.48e-05	4.73e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—ABCB1—adrenal gland cancer	1.48e-05	4.72e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—EGFR—adrenal gland cancer	1.47e-05	4.7e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—PTGS2—adrenal gland cancer	1.46e-05	4.68e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—POMC—adrenal gland cancer	1.46e-05	4.66e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—EGFR—adrenal gland cancer	1.45e-05	4.63e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—TP53—adrenal gland cancer	1.45e-05	4.63e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—POMC—adrenal gland cancer	1.45e-05	4.63e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	1.43e-05	4.58e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—EGFR—adrenal gland cancer	1.41e-05	4.5e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—CTNNB1—adrenal gland cancer	1.39e-05	4.46e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—CTNNB1—adrenal gland cancer	1.39e-05	4.43e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—PTGS2—adrenal gland cancer	1.37e-05	4.39e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—EGFR—adrenal gland cancer	1.35e-05	4.31e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—PTGS2—adrenal gland cancer	1.34e-05	4.3e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	1.34e-05	4.29e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—CTNNB1—adrenal gland cancer	1.33e-05	4.24e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—POMC—adrenal gland cancer	1.3e-05	4.16e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—EGFR—adrenal gland cancer	1.28e-05	4.09e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—TP53—adrenal gland cancer	1.27e-05	4.06e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—POMC—adrenal gland cancer	1.27e-05	4.06e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—EGFR—adrenal gland cancer	1.27e-05	4.05e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—EGFR—adrenal gland cancer	1.27e-05	4.05e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—TP53—adrenal gland cancer	1.25e-05	4e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—TP53—adrenal gland cancer	1.25e-05	4e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—TP53—adrenal gland cancer	1.24e-05	3.97e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CTNNB1—adrenal gland cancer	1.22e-05	3.91e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—TP53—adrenal gland cancer	1.22e-05	3.89e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CTNNB1—adrenal gland cancer	1.2e-05	3.85e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CTNNB1—adrenal gland cancer	1.2e-05	3.84e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	1.2e-05	3.83e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—POMC—adrenal gland cancer	1.2e-05	3.82e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CTNNB1—adrenal gland cancer	1.19e-05	3.82e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—POMC—adrenal gland cancer	1.18e-05	3.79e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CTNNB1—adrenal gland cancer	1.18e-05	3.78e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—TP53—adrenal gland cancer	1.18e-05	3.78e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CTNNB1—adrenal gland cancer	1.18e-05	3.77e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PTGS2—adrenal gland cancer	1.16e-05	3.72e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—GNAS—adrenal gland cancer	1.16e-05	3.71e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PTGS2—adrenal gland cancer	1.15e-05	3.69e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	1.14e-05	3.64e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—TP53—adrenal gland cancer	1.13e-05	3.62e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—EGFR—adrenal gland cancer	1.1e-05	3.53e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—EGFR—adrenal gland cancer	1.1e-05	3.51e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CTNNB1—adrenal gland cancer	1.09e-05	3.5e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—TP53—adrenal gland cancer	1.07e-05	3.43e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—TP53—adrenal gland cancer	1.06e-05	3.4e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—TP53—adrenal gland cancer	1.06e-05	3.4e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—EGFR—adrenal gland cancer	1.05e-05	3.36e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	1.04e-05	3.32e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—POMC—adrenal gland cancer	1.01e-05	3.24e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PTGS2—adrenal gland cancer	1.01e-05	3.24e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—EGFR—adrenal gland cancer	9.69e-06	3.1e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	9.53e-06	3.05e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—EGFR—adrenal gland cancer	9.53e-06	3.05e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—EGFR—adrenal gland cancer	9.51e-06	3.04e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—EGFR—adrenal gland cancer	9.48e-06	3.03e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	9.45e-06	3.02e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—EGFR—adrenal gland cancer	9.45e-06	3.02e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—EGFR—adrenal gland cancer	9.36e-06	2.99e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—EGFR—adrenal gland cancer	9.33e-06	2.99e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—TP53—adrenal gland cancer	9.26e-06	2.96e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—TP53—adrenal gland cancer	9.22e-06	2.95e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—TP53—adrenal gland cancer	8.82e-06	2.82e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—EGFR—adrenal gland cancer	8.67e-06	2.77e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—TP53—adrenal gland cancer	8.13e-06	2.6e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PTGS2—adrenal gland cancer	8.08e-06	2.58e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—TP53—adrenal gland cancer	8e-06	2.56e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—TP53—adrenal gland cancer	7.99e-06	2.56e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—TP53—adrenal gland cancer	7.96e-06	2.55e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—TP53—adrenal gland cancer	7.93e-06	2.54e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—TP53—adrenal gland cancer	7.86e-06	2.51e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—TP53—adrenal gland cancer	7.84e-06	2.51e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—POMC—adrenal gland cancer	7.81e-06	2.5e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—TP53—adrenal gland cancer	7.28e-06	2.33e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	6.23e-06	1.99e-05	CbGpPWpGaD
